Key points are not available for this paper at this time.
This month we focus on papers that provide insights into the potential for target trial emulation to be used in health technology assessment, the role of real-world evidence (RWE) in informing additional elements of value and the importance of RWE to European joint clinical assessments.
Simpson et al. (Wed,) studied this question.